Disease Progression Humans Lower Urinary Tract Symptoms/etiology Male Prostatic Hyperplasia/complications/*drug therapy Risk Factors Time Factors Treatment Outcome Benign prostatic hyperplasia Early treatment Luts Outcomes complications Pharmacological treatment Prostate Surgery

Adrenergic alpha-Antagonists Drug Therapy Combination Humans Lower Urinary Tract Symptoms Male Middle Aged Phosphodiesterase Inhibitors Prostatic Hyperplasia Randomized Controlled Trials as Topic

Antifibrinolytic Agents/*administration & dosage Blood Loss Surgical/*prevention & control Blood Transfusion/statistics & numerical data Humans Incidence Male Prostatectomy/*adverse effects Prostatic Hyperplasia/surgery Prostatic Neoplasms/surgery Thromboembolism/*epidemiology/etiology Tranexamic Acid/*administration & dosage *Anesthesia *Blood loss *Prostate *Review *Surgical *Systematic *Tranexamic acid

Humans Laser Therapy Male Patient Selection Preoperative Period Prostatic Hyperplasia/complications/physiopathology *Quality of Life Transurethral Resection of Prostate/*adverse effects/methods Treatment Outcome Urinary Bladder Underactive/etiology/*physiopathology *Urodynamics *muscle hypertonia *prostate *prostatic hyperplasia *urethra

Adrenergic alpha-Antagonists Benzilates Drug Combinations Ethamsylate Humans Indoles Lower Urinary Tract Symptoms Male Naphthalenes Piperazines Plant Extracts Prostatic Hyperplasia Prostatism Quality of Life Randomized Controlled Trials as Topic Sulfonamides Tamsulosin Urological Agents

Humans Laser Coagulation Laser Therapy Lasers Solid-State Male Non-Randomized Controlled Trials as Topic/statistics & numerical data Prostatic Hyperplasia/complications Quality of Life Randomized Controlled Trials as Topic/statistics & numerical data *Thulium Transurethral Resection of Prostate Treatment Outcome Ureteral Obstruction/etiology 2-micron Benign prostatic obstruction Plasmakinetic resection of prostate Safety and efficacy Thulium laser VapoResection of the prostate Thulium laser Transurethral resection of the prostate

*Alleles Ethnicity/genetics *Genetic Association Studies *Genetic Predisposition to Disease Genotype Humans Male Odds Ratio *Polymorphism Single Nucleotide Prostate-Specific Antigen/*genetics Prostatic Hyperplasia/*genetics Publication Bias Risk Factors Bph Psa meta-analysis polymorphism

Arteries Embolization Therapeutic/*adverse effects/methods/standards Humans Kallikreins/blood Lower Urinary Tract Symptoms/blood/etiology/*therapy Male Practice Guidelines as Topic Prostate/blood supply Prostate-Specific Antigen/blood Prostatic Hyperplasia/blood/complications/*therapy Quality of Life Treatment Outcome *arteries *embolization *investigational *prostatic hyperplasia *therapeutic *therapies *treatment outcome

Humans Male Prostate Prostatic Hyperplasia/surgery Treatment Outcome

5-alpha Reductase Inhibitors/pharmacology Blood Loss Surgical/*prevention & control Blood Transfusion Dutasteride/*pharmacology Hemoglobins/analysis Humans Male Microcirculation Prospective Studies Prostate Prostatic Hyperplasia Randomized Controlled Trials as Topic Retrospective Studies *Transurethral Resection of Prostate Treatment Outcome Vascular Endothelial Growth Factor A/metabolism Benign prostatic hyperplasia Dutasteride Intraoperative blood loss Meta-analysis Transurethral resection of the prostate

Aged Causality Comorbidity Embolization Therapeutic/*statistics & numerical data Follow-Up Studies Humans Longitudinal Studies Lower Urinary Tract Symptoms/*epidemiology/*prevention & control Male Middle Aged Prostate/blood supply Prostatic Hyperplasia/diagnostic imaging/*epidemiology/*therapy Risk Factors Treatment Outcome

Surgical Treatments Benign Prostatic Hyperplasia Male Erectile Function Meta-Analysis

Aged Embolization Therapeutic Humans Lower Urinary Tract Symptoms/complications/therapy Male Prostate/blood supply/diagnostic imaging Prostatic Hyperplasia/complications/*therapy Treatment Outcome Bph Prostate artery embolisation Quality of life

Aged Humans Male Middle Aged *Patient Selection Prostate/surgery Prostatic Hyperplasia Quality of Life *Transurethral Resection of Prostate Treatment Outcome Urinary Bladder Neck Obstruction *Urodynamics

Adrenergic alpha-Antagonists/administration & dosage/*therapeutic use Cholinergic Antagonists/administration & dosage Drug Therapy Combination Humans *Lower Urinary Tract Symptoms Male Prostatic Hyperplasia/*diagnosis/*drug therapy Publication Bias Quality of Life Treatment Outcome

Adrenergic alpha-1 Receptor Antagonists Aged Humans Indoles Lower Urinary Tract Symptoms Male Naphthalenes Piperazines Prostatic Hyperplasia Quinazolines Randomized Controlled Trials as Topic Urological Agents

benign prostatic hyperplasia clinical guidelines intravesical prostatic protrusion male lower urinary tract symptoms staging of clinical BPH

*Ejaculation Humans Male Prostatic Hyperplasia/complications Prostatism/etiology Randomized Controlled Trials as Topic Sexual Dysfunction Physiological/*etiology/physiopathology Urologic Surgical Procedures Male/*adverse effects benign prostatic hyperplasia decreased ejaculation ejaculatory dysfunction lower urinary tract symptoms painful ejaculation retrograde ejaculation

5-alpha Reductase Inhibitors/*adverse effects Drug Therapy Combination Ejaculation/drug effects Erectile Dysfunction/*chemically induced/drug therapy Finasteride Humans Libido/*drug effects Male Middle Aged Prostatic Hyperplasia/*drug therapy Randomized Controlled Trials as Topic *5α-Reductase Inhibitors *Erectile Dysfunction *Meta-Analysis *Sexual Dysfunction

Follow-Up Studies Humans Length of Stay Male Operative Time Postoperative Complications/etiology Prostatic Hyperplasia/complications Prostatism/etiology *Prostheses and Implants Quality of Life Severity of Illness Index Time Factors